La protonterapia debuta en España de la mano del mejor talento médico internacional
La protonterapia española de Quirónsalud Madrid en las manos del mejor talento médico internacional, el único centro de estas características en España.
Related Articles
EHA Library – The official digital education library of European Hematology Association (EHA)
Access educational materials, eLearning activities, accredited Live webinar sessions with polls and chat on this fast Digital Library and Hybrid Virtual Event Platform powered by…
ASH Global Research Award
The ASH Global Research Award works to support future international scientific leaders, increase capacity, and nurture global collaboration amongst hematologist who are between the completion…
Characteristics and outcomes of patients with double refractory and double exposed chronic lymphocytic leukemia
Key PointsThe median OS of patients with DR CLL whose disease progressed during BTK and BCL2 inhibition was 2.2 years.DE CLL represented a less aggressive
Impact of vein-to-vein time in patients with R/R LBCL treated with axicabtagene ciloleucel
Key PointsPatients with R/R LBCL had the shortest median V2Vt with axi-cel, 30.6 days, compared with tisa-cel, 48.4 days, or liso-cel, 35.9 days.Complete r
Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review
Abstract. The disease shift of chronic lymphocytic leukemia (CLL) to diffuse large B-cell lymphoma (DLBCL), so-called Richter transformation (RT), is a cat
Nuevos horizontes para la especialidad de hematología y hemoterapia
Dra. María Victoria Mateos Manteca, presidenta de la Sociedad Española de Hematología y Hemoterapia (SEHH)
La hematología española despunta internacionalmente en terapias avanzadas
Pero no sólo con CAR T académicos como el desarrollado por el Hospital Clínic de Barcelona sino también frente a hemopatías malignas como el mieloma…
Outcomes among adult recipients of CAR T-cell therapy for Burkitt lymphoma
Key PointsDespite having relatively favorable disease kinetics, patients with relapsed/refractory BL who receive CAR T cells have poor outcomes.Future tria
Efficacy and safety of CAR T‐cell therapy in patients with primary or secondary CNS lymphoma: A study on behalf of the EBMT and the GoCART coalition
Patients with relapsed or refractory (r/r) primary central nervous system (CNS) lymphoma (PCNSL) or secondary central nervous system (CNS) lymphoma (SCNSL) face a dismal prognosis.…
Identifying Older Adults at Risk of Accelerated Decline in Gait Speed and Grip Strength: Insights from the National Health and Aging Trends Study (NHATS)
Gait speed and grip strength are widely used measures of physical function in older adults and are predictive of disability, hospitalization, and mortality. However, there…